Navigating the Breast Cancer Journey
Hours: 1.50
Breast cancer is the most common cancer (excluding skin cancer) that many women may face in their lifetime. This course covers breast cancer modifiable and non-modifiable risk factors and screening recommendations and provides an overview of the diagnostics, staging, and prognostic factors for localized, invasive, and metastatic breast cancer. The course provides an overview of treatment modalities and associated adverse events.
The goal of this course is to provide nurses and pharmacists with an update on breast cancer screening and treatment.
Breast cancer is the most common cancer (excluding skin cancer) that many women may face in their lifetime. This course covers breast cancer modifiable and non-modifiable risk factors and screening recommendations and provides an overview of the diagnostics, staging, and prognostic factors for localized, invasive, and metastatic breast cancer. The course provides an overview of treatment modalities and associated adverse events. The goal of this course is to provide nurses and pharmacists with an update on breast cancer screening and treatment.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.50 contact hours for participating in this course.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.50 Nursing Contact Hours after successfully completing this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.50 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Michigan Board of Nursing
Wyoming Board of Nursing
Wyoming Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Kansas State Board of Nursing
Kansas State Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: [Custom_Code]
Target Audience Designation: [Custom_Code2]
ACPE Universal Activity Number: JA4008266-0000-23-003-H01-P
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 1.50 contact hours.
Michigan Board of Pharmacy
Michigan Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 1.50 contact hours.
Identify modifiable and non-modifiable factors for breast cancer, detection guidelines, and diagnostic modalities.
Define treatment modalities for breast cancer, factors that help with prognosis and treatment decisions for patients with breast cancer, and adverse effects of treatment.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Breast Cancer Risk Factors
Statistics
Lifestyle Risk Factors
Non-Modifiable Risk Factors
Hereditary Breast and Ovarian Cancer (HBOC) Syndrome
Other Risk Factors
Review
Section 3: Screening and Diagnosis
Identifying Breast Cancer
Average Risk
Increased Risk
Clinical Breast Exam (CBE)/Breast Self-Exam (BSE)
Biopsy
Types of Breast Cancer
Review
Section 4: Staging
Extent and Prognosis
TNM Clinical Staging Classification
Evaluation and Workup
Prognostic Factors
After a Diagnosis
Review
Section 5: Treatment
Interprofessional Team
Surgery: A Choice
Mastectomy
Lumpectomy
Breast Prosthesis and Reconstruction
Radiation Therapy
Brachytherapy (Internal Radiation)
Chemotherapy
Targeted Therapies
Hormone Therapy
Immunotherapy
Review
Section 6: Conclusion
Course Summary
Course Contributor
Resources
ReferencesSubject Matter Expert: Monica Caicedo Orellana, MS, RN, OCN, CNE
Monica Caicedo Orellana, MS, RN, OCN, is an SME writer for Relias with over 16 years of acute care experience in nursing. She is licensed as a professional registered nurse in the State of New York. She obtained her OCN certification in 2008. She has served in several leadership roles in the acute care setting, within the Medical Surgical Division, mentoring nurses in renal and oncology specialties, and the role of nurse educator. She has been involved in various institutional committees and quality improvement projects. Monica earned a master’s degree in nursing education from New York University Rory Meyers College of Nursing.
Disclosure: Monica Caicedo Orellana, MS, RN, OCN, CNE has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
The target audience for this course is: Nurses; Pharmacists; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
